- pause slideshow
Evidence is emerging that biocides and heavy metals all contribute to the growing problem of antimicrobial resistance.
Previous court cases concerning informed consent of treatment have raised questions about what consent means in relation to pharmacists, medicines and prescribing.
William Seligman takes a look at what might happen to the US healthcare system and pharma under a Trump presidency.
UK drug funding framework needs an overhaul to ensure the right areas are being prioritisedSubscription
If the NHS is to get value for money from medicines, it needs to consider what the UK population values and where its priorities lie.
Your RPS needs youSubscription
Show your passion and dedication to pharmacy by putting yourself forward for this year’s RPS national pharmacy board elections.
Recommendations made in Murray’s review for community pharmacy will not be simple to implementSubscription
Practical challenges, including building closer relationships with GPs, will need to be overcome if the recommendations in the Murray review on community pharmacy are to be implemented successfully.
We need fewer empty promises and more action and progress with rebalancing medicines legislation and pharmacy regulation — particularly around dispensing errors.
Reclassifying emergency hormonal contraception levonorgestrel from a pharmacy to general sale medicine is not the answerSubscription
Instead of making levonorgestrel available to purchase in any retail outlet without medical advice, it would be better to improve emergency hormonal contraception consultations, lower the price of the medicine and make it more easily accessible via national patient group directions.
There are a number of factors that contribute to patients’ fear and reluctance to take osteoporosis drugs, leaving them at increased risk of fractures.
Research suggests no substantive outcome differences between the use of originator biologics and their biosimilar counterparts Source: Shutterstock.com
Caution is required when prescribing or dispensing long-acting beta agonists to manage airways diseases, such as asthma.
Since the dawn of hormonal replacement therapy — now known as menopausal hormone therapy — there have been conflicting reports about its risks and safety. A thorough examination of the evidence suggests it can be used safely in menopausal women.
Six candidates in the race to be director-general of the World Health Organization outline their priorities and vision for global health.
Maree Todd, pharmacist and member of the Scottish Parliament, speaks to Jenny Bryan about the successes of community pharmacy in Scotland, what can England learn from them and her life in politics so far.
In light of the government’s intention to cut funding for the sector and reform the remuneration structure, we asked four people from four different community pharmacy backgrounds to share their views.
Q&A: World Bank warns that inaction on antimicrobial resistance could increase healthcare costs in developing countriesSubscription
Tim Evans from the World Bank Group talks about new research that shows how inaction on antimicrobial resistance could wipe out decades of healthcare gains and dramatically increase healthcare costs in developing countries.
Introduction to drug disposition and pharmacokinetics, by Stephen H Curry and Robin Whelpton
Life histories of genetic disease: patterns and prevention in postwar medical genetics by Andrew J Hogan
A taste of his own medicine, by Linda Fawke
Building a case on the harm of sugarSubscription
The case against sugar, by Gary Taubes
After seven years in the pharmacy world, Helen Gordon is departing as chief executive of the Royal Pharmaceutical Society to enter pastures new at the Royal Society of Medicine. Here, she talks to Julia Robinson about her proudest moments and what advice she would give to her successor.
Catherine Duggan, director of professional development at the Royal Pharmaceutical Society (RPS) and Ian Bates, education adviser to the RPS English Pharmacy Board, discuss the importance of developing a global standard of education and training for pharmacists.
The 2017 Royal Pharmaceutical Society (RPS) budget, agreed in November 2016, includes a financial surplus of £5,000 before interest. Here Simon Redman, director of finance at the RPS, talks to Julia Robinson about how the RPS has recovered from last year’s budgeted loss of £1.5m and what plans are being made to improve services and engage with members in the coming year.
Sandra Gidley, chair of the RPS English Pharmacy Board, makes the case for the integration of health and social care funding and explains why pharmacists are needed across the entire health and social care system and at all levels of the NHS.
Mixed reviews about The Pharmaceutical JournalSubscription
I have read The Pharmaceutical Journal since the days of my pharmacy apprenticeship. I have always valued my receipt of it, have always found items of interest and value in it, and I continue to do so to this day. In addition, even though I go online to the website three or four times a week, I still find fresh items of interest or value when I receive the print edition.
Warning about potential data loss in pharmaciesSubscription
I write to warn fellow contractors in community pharmacy about a major IT issue that affects storage of patient data.
Superior shelf-life of EmeradeSubscription
Last summer, I went into anaphylactic shock after being stung by a wasp. When I had recovered, my GP said I should carry an adrenaline auto-injector pen with me and we chose the Emerade brand rather than Epipen because, in addition to having a higher and more realistic dosage (500μg) it had a 30-month shelf life compared with only 18 months for Epipen.
Scrap the opioid substitution serviceSubscription
I am a locum pharmacist who has worked in pharmacies in various regions of England. In many of the pharmacies I work in, I dispense methadone or buprenorphine to substance misusers and also provide clean needle packs as requested. It is disturbing for me to see drug misusers collect their methadone or buprenorphine doses and also request needles.
2017 could see a rise in patient-centred technologies across pharmacy. Martin Hao, managing director at Healthera, a new medicines management app, looks at the reasons behind the trend.
Additional funding for R&D post-Brexit is a welcome move from the UK government, but there are other related issues to consider as well.
A round up of the most popular news stories of 2016.
In a climate where science and facts appear to play second fiddle to post-truth rants on social media, Cynthia Leifer explains why activism and public engagement must become part of the everyday work of scientists and physicians.
Thomas Geoffrey Booth (1928-2016)Subscription
Thomas Geoffrey Booth, past president of the Royal Pharmaceutical Society, founded the UK’s first department of pharmacy practice.
Frank P Palopoli (1922–2016) Subscription
The scientist who discovered the fertility drug clomifene was known as a modest man who mentored his staff.
Kirit Patel (1949-2016)Subscription
A self-made man who started out wanting to own a shop to support his family, Kirit Patel’s lifetime achievements are inspirational.
Philip Majerus (1936-2016)Subscription
Majerus was one of the first researchers who discovered the benefits of low dose aspirin in preventing heart attacks and strokes.